Professor Alastair Compston

MB BS; PhD; FRCP; FMedSci. 

Miss Katrina Dedman
Professional bodies : 

Member, Association of British Neurologists.

Fellow, Royal Society of Arts.

Fellow, Institute of Biology.

Foreign Member of the National Academy of Sciences of Germany

Foreign Associate Member of the Institute of Medicine of the National Academies of the USA.

Recipient of the Sobek Foundation International Research Prize; the Charcot Award of Multiple Sclerosis International Federation; The KJ Zulch Prize of the Max Planck Society and the McDonald Award of the MS Society of Great Britain and Northen Ireland.

GMC number: 

General neurology

Demyelinating disease

Alastair Compston has a special interest in human demyelinating disease with experience during the last 30 years as a consultant neurologist seeing patients with multiple sclerosis and related disorders.  His research focuses on the clinical science of human demyelinating disease with contributions to the genetic epidemiology, immunology and neurobiology, and treatment and repair. He introduced the treatment of multiple sclerosis with Alemtuzumab in 1991 and has remained closely connected with the clinical trials programme that concluded in 2012 using this humanised monoclonal antibody in early relapsing remitting multile sclerosis.  Alastair Compston sees patients with multiple sclerosis in the general neurology clinic at Addenbrooke’s; and he is responsible with others for the provision of general neurological services at Hinchingbrooke Hospital, Huntingdon.